To investigate the stroma-mediated drug sensitivity of NSCLC tumor cells, we established 3D cultures of EML4-ALK translocation carrying H2228 (E6; A20) and H3122 (E13; A20) cells with and without CAFs (Fig. 1A). The gene discussed is ALK; the disease is non-small cell lung carcinoma.